NCT01230983
Clinical Trial Information
Trial Number: NCT01230983 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Leukemia - Acute Lymphoblastic Leukemia
- Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
Trial Title:
Intensive Treatment For T-CELL Acute Lymphoblastic Leukemia and Advanced Stage Lymphoblastic Non-Hodgkin's Lymphoma: A Pediatric Oncology Group Phase III Study
Study ID:
POG-9404
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01230983-D2 | Dataset 2 Description: NCT01230983-D2 is the subset of the 239 patients with data on Troponin levels. These data were used in the mixed model analyses to assess the effect of Dexrazoxane on the probability of an elevated troponin concentration during treatment. |
| NCT01230983-D1 | Dataset 1 Description: NCT01230983-D1 includes all patients enrolled on the study. This dataset will allow users to reproduce all analyses presented in the manuscript both overall and comparison of the Doxorubicin versus Doxorubicin + Dexrazoxane arms. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®